Rekah Pharmaceutical Industry Ltd (REKA) — Free Cash Flow Generation Index
Rekah Pharmaceutical Industry Ltd (REKA) has a Free Cash Flow Generation Index of 0.60x as of December 2025. Free cash flow of ILA3.17 Million represents 1% of operating cash flow (ILA5.27 Million). See Rekah Pharmaceutical Industry Ltd (REKA) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Rekah Pharmaceutical Industry Ltd Free Cash Flow Generation Index (2002–2025)
Historical FCF Generation Index trend for Rekah Pharmaceutical Industry Ltd across 21 annual periods. Explore Rekah Pharmaceutical Industry Ltd (REKA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Rekah Pharmaceutical Industry Ltd (2002–2025)
Year-by-year Free Cash Flow Generation Index for Rekah Pharmaceutical Industry Ltd. For the full company profile including market capitalisation, see REKA market cap.
| Year | FCG Index | Free Cash Flow (ILA) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | ILA5.92 Million | ILA12.95 Million | ILA7.03 Million | ▼ -32.0% |
| 2024 | 0.67x | ILA17.84 Million | ILA26.54 Million | ILA8.70 Million | ▲ +13.0% |
| 2023 | 0.59x | ILA16.86 Million | ILA28.35 Million | ILA11.49 Million | ▼ -26.4% |
| 2022 | 0.81x | ILA31.52 Million | ILA39.00 Million | ILA7.48 Million | ▲ +138.4% |
| 2021 | 0.34x | ILA7.17 Million | ILA21.17 Million | ILA13.99 Million | ▲ +150.6% |
| 2020 | -0.67x | ILA-7.55 Million | ILA11.28 Million | ILA18.84 Million | ▼ -97.6% |
| 2019 | -0.34x | ILA-11.48 Million | ILA33.91 Million | ILA45.40 Million | ▼ -377.7% |
| 2018 | 0.12x | ILA2.11 Million | ILA17.28 Million | ILA15.18 Million | ▼ -60.3% |
| 2017 | 0.31x | ILA7.32 Million | ILA23.80 Million | ILA16.48 Million | ▼ -25.2% |
| 2016 | 0.41x | ILA9.38 Million | ILA22.82 Million | ILA13.44 Million | ▲ +132.5% |
| 2015 | -1.26x | ILA-7.34 Million | ILA5.81 Million | ILA13.15 Million | ▲ +90.6% |
| 2014 | -13.49x | ILA-17.94 Million | ILA1.33 Million | ILA19.27 Million | ▼ -2256.8% |
| 2013 | 0.63x | ILA7.32 Million | ILA11.71 Million | ILA4.38 Million | ▲ +103.3% |
| 2012 | 0.31x | ILA4.36 Million | ILA14.18 Million | ILA9.82 Million | ▼ -85.8% |
| 2010 | 2.17x | ILA14.61 Million | ILA6.73 Million | ILA7.87 Million | ▲ +59.7% |
| 2009 | 1.36x | ILA35.36 Million | ILA26.03 Million | ILA9.33 Million | ▼ -48.4% |
| 2008 | 2.63x | ILA17.30 Million | ILA6.57 Million | ILA10.73 Million | ▲ +84.9% |
| 2007 | 1.42x | ILA17.73 Million | ILA12.45 Million | ILA5.28 Million | ▼ -46.4% |
| 2005 | 2.66x | ILA11.36 Million | ILA4.27 Million | ILA7.09 Million | ▲ +110.5% |
| 2004 | 1.26x | ILA22.57 Million | ILA17.87 Million | ILA4.70 Million | ▲ +3.7% |
| 2002 | 1.22x | ILA13.64 Million | ILA11.21 Million | ILA2.44 Million | — |